1. Multidimensional mass profiles increase confidence in bacterial identification when using low-resolution mass spectrometers.
- Author
-
Sasiene, Zachary J., LeBrun, Erick S., Velappan, Nileena, Anderson, Austin R., Patterson, Nathan H., Dufresne, Martin, Farrow, Melissa A., Norris, Jeremy L., Caprioli, Richard M., Mach, Phillip M., McBride, Ethan M., and Glaros, Trevor G.
- Subjects
- *
MATRIX-assisted laser desorption-ionization , *TANDEM mass spectrometry , *MASS spectrometers , *YERSINIA pestis , *TECHNOLOGICAL innovations , *MASS spectrometry , *DAUGHTER ions - Abstract
Field-forward analytical technologies, such as portable mass spectrometry (MS), enable essential capabilities for real-time monitoring and point-of-care diagnostic applications. Significant and recent investments improving the features of miniaturized mass spectrometers enable various new applications outside of small molecule detection. Most notably, the addition of tandem mass spectrometry scans (MS/MS) allows the instrument to isolate and fragment ions and increase the analytical specificity by measuring unique chemical signatures for ions of interest. Notwithstanding these technological advancements, low-cost, portable systems still struggle to confidently identify clinically significant organisms of interest, such as bacteria, viruses, and proteinaceous toxins, due to the limitations in resolving power. To overcome these limitations, we developed a novel multidimensional mass fingerprinting technique that uses tandem mass spectrometry to increase the chemical specificity for low-resolution mass spectral profiles. We demonstrated the method's capabilities for differentiating four different bacteria, including attentuated strains of Yersinia pestis. This approach allowed for the accurate (>92%) identification of each organism at the strain level using de-resolved matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) data to mimic the performance characteristics of miniaturized mass spectrometers. This work demonstrates that low-resolution mass spectrometers, equipped with tandem MS acquisition modes, can accurately identify clinically relevant bacteria. These findings support the future application of these technologies for field-forward and point-of-care applications where high-performance mass spectrometers would be cost-prohibitive or otherwise impractical. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF